Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.25 -0.03 (-2.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sonoma Pharmaceuticals (SNOA) Return on Equity [ROE] (2011 - 2026)

Updated

Sonoma Pharmaceuticals' Return on Equity [ROE] was -46.73% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 37.24 percentage points from -83.97% a year earlier and up 50.55 percentage points from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Return on Equity [ROE] at Sonoma Pharmaceuticals came in at -84.60%, down 19.05 percentage points from FY2025.

  • Return on Equity [ROE] shows a five-year change of -12.70 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Equity [ROE] was -65.55% in FY2025 (+2.97 pp), -68.51% in FY2024 (-6.73 pp), -61.78% in FY2023 (+10.56 pp) and -72.35% in FY2022 (-0.44 pp).
  • The fiscal Q1 2027 figure marks the highest quarterly Return on Equity [ROE] since fiscal Q4 2021.
  • Compared with a year earlier, Return on Equity [ROE] was higher in four of the last eight quarters, with an average year-over-year change of +1.08 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q1 2023 (a gain of 47.39 percentage points); the worst was fiscal Q3 2023 (a drop of 56.62 percentage points).
  • Per Business Quant data, SNOA's Return on Equity [ROE] in the three fiscal quarters before Q1 2027 was -97.29% (Q4 2026), -93.36% (Q3 2026) and -88.72% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 10.39%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 17.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 10.44%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -3.90%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 14.31%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 9.53%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 3.88%
10 Sonoma Pharmaceuticals 4.92 Mn -8.41 Mn 2.58 Mn -46.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46.73%
Mar 31, 2026 -97.29%
Dec 31, 2025 -93.36%
Sep 30, 2025 -88.72%
Jun 30, 2025 -83.97%
Mar 31, 2025 -74.50%
Dec 31, 2024 -73.33%
Sep 30, 2024 -71.39%
Jun 30, 2024 -82.07%
Mar 31, 2024 -75.38%
Dec 31, 2023 -82.09%
Sep 30, 2023 -95.21%
Jun 30, 2023 -74.67%
Mar 31, 2023 -76.11%
Dec 31, 2022 -107.90%
Sep 30, 2022 -77.33%
Jun 30, 2022 -58.54%
Mar 31, 2022 -51.20%
Dec 31, 2021 -51.28%
Sep 30, 2021 -68.50%
API Access

Sonoma Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SNOA&period=max&api_key=YOUR_API_KEY